Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
2(22%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
11%
Ph phase_1
8
89%

Phase Distribution

8

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
8(88.9%)
Phase 2Efficacy & side effects
1(11.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(7)

Detailed Status

Completed7
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 18 (88.9%)
Phase 21 (11.1%)

Trials by Status

recruiting222%
completed778%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9